Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spine Asia CoROCO:6758 80 EV-to-FCF is 16.57 as of Jul. 18, 2026, which is 58% below its 10-year median of 39.34. GuruFocus rates ROCO:6758 with a GF Score™ of 80/100 and a GF Value™ of NT$48.62 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Spine Asia Co ranks better than 65.22% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Spine Asia Co's Enterprise Value is NT$466.9 Mil.
Spine Asia Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$28.2 Mil. Therefore, Spine Asia Co's EV-to-FCF for today is 16.57.
The historical rank and industry rank for Spine Asia Co's EV-to-FCF or its related term are showing as below:
ROCO:6758'
s EV-to-FCF Range Over the Past 10 Years
Min: 16.04 Med: 39.34 Max: 1547.33
Current: 16.93
During the past 10 years, the highest EV-to-FCF of Spine Asia Co was 1547.33. The lowest was 16.04. And the median was 39.34.
ROCO:6758's EV-to-FCF is ranked better than 65.22% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.635
vs ROCO:6758: 16.93
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Spine Asia Co's PE Ratio (TTM) for today is calculated as:
Spine Asia Co's share price for today is NT$29.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spine Asia Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Spine Asia Co EV-to-FCF Related Terms
Spine Asia Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Spine Asia Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Spine Asia Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spine Asia Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spine Asia Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Spine Asia Co's EV-to-FCF falls into.
Spine Asia Co's current Enterprise Value is NT$466.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spine Asia Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$28.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spine Asia Co (ROCO:6758) has a EV-to-FCF of 16.57 as of Jul. 18, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Spine Asia Co and its competitors. This is 58% below median its historical median of 39.34. Over the past decade, Spine Asia Co's EV-to-FCF has ranged from 16.04 to 1,547.33. According to the industry distribution chart, Spine Asia Co ranks #144 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 34.8%.
Is Spine Asia Co's EV-to-FCF too high?
Spine Asia Co's current EV-to-FCF of 16.57 is 58% below median its 10-year median of 39.34. Over the past 10 years, this metric has ranged from a low of 16.04 to a high of 1,547.33. The Medical Devices & Instruments industry median EV-to-FCF is 23.64. Spine Asia Co's value of 16.57 is 29.9% below this industry median. Based on the distribution chart, Spine Asia Co ranks #144 out of 414 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Spine Asia Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spine Asia Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spine Asia Co ranks #144 out of 414 companies for EV-to-FCF. This puts Spine Asia Co in the upper half of its industry. The industry median EV-to-FCF is 23.64. Spine Asia Co's value of 16.57 is 29.9% below this benchmark. Historically, Spine Asia Co's own EV-to-FCF has ranged from 16.04 to 1,547.33 over the past decade. While the company's 10-year median is 39.34 vs. the industry median of 23.64, Spine Asia Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.64, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spine Asia Co's current EV-to-FCF of 16.57 is 29.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Spine Asia Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spine Asia Co's current EV-to-FCF is 16.57, which is 58% below median its own 10-year median of 39.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spine Asia Co stock overvalued right now?
Based on GuruFocus' analysis, Spine Asia Co (ROCO:6758) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$48.62, compared to a current price of NT$29.25 — trading 39.8% below its estimated fair value. The current EV-to-FCF is 16.57, which is 58% below median its 10-year median of 39.34 and 29.9% below the Medical Devices & Instruments industry median of 23.64. Spine Asia Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Spine Asia Co (ROCO:6758), the current EV-to-FCF is 16.57 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spine Asia Co (ROCO:6758) Overvalued in 2026?
Based on GuruFocus' analysis, Spine Asia Co stock appears to be undervalued.
The current stock price of NT$29.25 is trading 39.8% below its estimated GF Value™ of NT$48.62.
GuruFocus considers Spine Asia Co to be Significantly Undervalued.
Key valuation signals for ROCO:6758:
EV-to-FCF: 16.57 (58% below median its 10-year median of 39.34)
GF Value™: NT$48.62 vs. price of NT$29.25 (39.8% below fair value)
Industry Position: 29.9% below the Medical Devices & Instruments median (#144 of 414)
No single metric tells the full story. See the ROCO:6758 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spine Asia Co Ltd is a medical device company. It is engaged in the research, development, manufacturing, and marketing of spinal, implants and instruments. The company offers products such as vigor lumbar peek cage, remond polymer cervical cage, and combo cervical disc cage.
80GF Score
Get the complete analysis for ROCO:6758
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6758 has been successfully added to your 
